Sergio Li Calzi Selected Research

Sirtuins

1/2023

Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergio Li Calzi Research Topics

Disease

13	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2023 - 01/2006
7	Inflammation (Inflammations) 01/2023 - 04/2012
6	Ischemia 04/2013 - 01/2006
5	Type 2 Diabetes Mellitus (MODY) 11/2023 - 12/2009
5	Hypoxia (Hypoxemia) 01/2023 - 07/2006
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2023 - 11/2019
3	Vascular System Injuries 04/2013 - 10/2009
2	Obesity 02/2023 - 01/2020
2	Infarction (Infarctions) 01/2020 - 01/2019
2	Blindness (Hysterical Blindness) 11/2019 - 03/2010
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2018 - 04/2011
2	Rupture 01/2017 - 06/2009
2	Hyperoxia 11/2012 - 04/2012
2	Macular Edema 09/2012 - 03/2010
2	Pathologic Neovascularization 01/2012 - 05/2010
1	Myocardial Infarction 04/2024
1	Hemorrhage 11/2023
1	Aneurysm (Aneurysms) 11/2023
1	Hyperemia 11/2023
1	Hyperglycemia 01/2023
1	Gliosis 01/2021
1	Prediabetic State (Prediabetes) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2020
1	Diabetes Mellitus 11/2019
1	Hyperalgesia 01/2017
1	Proliferative Vitreoretinopathy 06/2013
1	Fibrosis (Cirrhosis) 06/2013
1	Metabolic Diseases (Metabolic Disease) 01/2013
1	Lung Injury 11/2012
1	Neuroinflammatory Diseases 09/2012
1	Eye Diseases (Eye Disease) 04/2011
1	Diabetic Angiopathies (Diabetic Angiopathy) 12/2009
1	Choroidal Neovascularization 06/2009
1	Burns 06/2009
1	Infections 01/2009
1	Retinal Degeneration 01/2009
1	Insulinoma 10/2006
1	Pituitary Neoplasms (Pituitary Adenoma) 10/2006
1	Retinal Neovascularization 07/2006

Drug/Important Bio-Agent (IBA)

17	Retinaldehyde (Retinal)IBA 11/2023 - 07/2006
7	erucylphosphocholineIBA 01/2013 - 01/2006
6	Oxygen (Dioxygen)IBA 01/2021 - 07/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 07/2006
4	DipeptidesIBA 01/2018 - 07/2006
4	arginyl-glutamineIBA 01/2018 - 07/2006
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2009
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2006
3	Docosahexaenoic AcidsIBA 01/2018 - 04/2012
3	Insulin-Like Growth Factor Binding Protein 3IBA 01/2012 - 10/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2006
2	Sirtuin 1IBA 01/2023 - 01/2021
2	Angiotensin-Converting Enzyme 2IBA 11/2019 - 01/2018
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018 - 01/2013
2	Insulin (Novolin)FDA Link 01/2012 - 10/2006
1	tdTomatoIBA 04/2024
1	LipofuscinIBA 11/2023
1	TrypsinIBA 11/2023
1	SirtuinsIBA 01/2023
1	Glycogen Synthase Kinase 3 betaIBA 01/2023
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2023
1	SRT1720IBA 01/2021
1	CholesterolIBA 01/2020
1	LigandsIBA 01/2020
1	Liver X ReceptorsIBA 01/2020
1	16S Ribosomal RNAIBA 11/2019
1	Fatty Acid-Binding ProteinsIBA 11/2019
1	Peptidoglycan (Murein)IBA 11/2019
1	protectin D1IBA 01/2018
1	Propranolol (Inderal)FDA LinkGeneric 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Insulin-Like Growth Factor Binding Protein 5IBA 06/2013
1	Streptozocin (Streptozotocin)FDA Link 04/2013
1	RNA (Ribonucleic Acid)IBA 01/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2012
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2012
1	Glutamine (L-Glutamine)FDA Link 04/2012
1	N-hydroxysuccinimide suberic acid ester (DSIS)IBA 04/2012
1	Arginine (L-Arginine)FDA Link 04/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2012
1	CalciumIBA 01/2012
1	Green Fluorescent ProteinsIBA 10/2009
1	monocrystalline iron oxide nanoparticle (MION)IBA 06/2009
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 01/2009
1	Retinal Pigments (Pigments, Visual)IBA 01/2009
1	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 06/2007
1	Insulin-Like PeptidesIBA 06/2007
1	matrigelIBA 03/2007
1	SecurinIBA 10/2006
1	enhanced green fluorescent proteinIBA 10/2006
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2006
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2006
1	OccludinIBA 01/2006

Therapy/Procedure

2	Therapeutics 09/2012 - 03/2010
2	Lasers (Laser) 10/2009 - 06/2009
1	Ligation 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2013
1	Denervation 12/2009
1	Intravitreal Injections 10/2009